These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31300915)
1. Immunization with recombinant fusion of LTB and linear epitope (40-62) of epsilon toxin elicits protective immune response against the epsilon toxin of Clostridium perfringens type D. Kaushik H; Deshmukh SK; Solanki AK; Bhatia B; Tiwari A; Garg LC AMB Express; 2019 Jul; 9(1):105. PubMed ID: 31300915 [TBL] [Abstract][Full Text] [Related]
2. Recombinant expression of in silico identified Bcell epitope of epsilon toxin of Clostridium perfringens in translational fusion with a carrier protein. Kaushik H; Deshmukh S; Mathur DD; Tiwari A; Garg LC Bioinformation; 2013; 9(12):617-21. PubMed ID: 23904738 [TBL] [Abstract][Full Text] [Related]
3. B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: expression, purification and characterization of the chimeric protein. Bhatia B; Solanki AK; Kaushik H; Dixit A; Garg LC Protein Expr Purif; 2014 Oct; 102():38-44. PubMed ID: 24996028 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid. Kaushik H; Dixit A; Garg LC Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342 [TBL] [Abstract][Full Text] [Related]
5. Design of a chitosan-based nano vaccine against epsilon toxin of Poorhassan F; Nemati F; Saffarian P; Mirhosseini SA; Motamedi MJ Res Pharm Sci; 2021 Dec; 16(6):575-585. PubMed ID: 34760006 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity assessment of Clostridium perfringens type D epsilon toxin epitope-based chimeric construct in mice and rabbit. Singh AP; Prabhu SN; Nagaleekar VK; Dangi SK; Prakash C; Singh VP 3 Biotech; 2020 Sep; 10(9):406. PubMed ID: 32864287 [TBL] [Abstract][Full Text] [Related]
7. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis. Wang Y; Miao Y; Hu LP; Kai W; Zhu R Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084 [TBL] [Abstract][Full Text] [Related]
8. Recombinant unpurified rETX Peng X; Li X; Peng G; Feng L; Jiang Y; Luo Y J Vet Med Sci; 2021 Apr; 83(3):441-446. PubMed ID: 33551442 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a recombinant Lactobacillus casei, surface-expressed H Alimolaei M; Golchin M; Baluch-Akbari A Toxicon; 2021 Sep; 200():173-179. PubMed ID: 34324946 [TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization. Souza AM; Reis JK; Assis RA; Horta CC; Siqueira FF; Facchin S; Alvarenga ER; Castro CS; Salvarani FM; Silva RO; Pires PS; Contigli C; Lobato FC; Kalapothakis E Genet Mol Res; 2010 Feb; 9(1):266-76. PubMed ID: 20198582 [TBL] [Abstract][Full Text] [Related]
11. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia. Li Q; Xin W; Gao S; Kang L; Wang J Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363 [TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of Aziminia P; Pilehchian-Langroudi R; Esmaeilnia K Iran J Microbiol; 2016 Aug; 8(4):226-231. PubMed ID: 28210460 [TBL] [Abstract][Full Text] [Related]
13. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model. Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504 [TBL] [Abstract][Full Text] [Related]
14. Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep. Jiang Z; Chang J; Wang F; Qi Y; Li Y; Yu D; Yu L Vaccine; 2020 Sep; 38(42):6553-6561. PubMed ID: 32788135 [TBL] [Abstract][Full Text] [Related]
15. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia. Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588 [TBL] [Abstract][Full Text] [Related]
16. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2. Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068 [TBL] [Abstract][Full Text] [Related]
17. Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Fernandez-Miyakawa ME; Fisher DJ; Poon R; Sayeed S; Adams V; Rood JI; McClane BA; Uzal FA Infect Immun; 2007 Mar; 75(3):1443-52. PubMed ID: 17210666 [TBL] [Abstract][Full Text] [Related]
18. Expression of Clostridium perfringens epsilon-beta fusion toxin gene in E. coli and its immunologic studies in mouse. Pilehchian Langroudi R; Shamsara M; Aghaiypour K Vaccine; 2013 Jul; 31(32):3295-9. PubMed ID: 23707696 [TBL] [Abstract][Full Text] [Related]
19. Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Sayeed S; Fernandez-Miyakawa ME; Fisher DJ; Adams V; Poon R; Rood JI; Uzal FA; McClane BA Infect Immun; 2005 Nov; 73(11):7413-21. PubMed ID: 16239541 [TBL] [Abstract][Full Text] [Related]